Patent · US Active

Branched oligonucleotides

US10478503B2 · kind B2 · utility

14Cited by
35References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2017
Grant dateNov 19, 2019
Priority date
Expiry dateJan 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.